Author Information: Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (M.M., B.O.J., S.R., K.H.); Oncology Unit, Alder Hey Children’s Hospital, Liverpool, UK (B.P.); Brain Tumor Programme, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France (C.D.); Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands (D.V.); Second Department of Pediatrics, School of Medicine, Semmelweis University, Budapest, Hungary (M.G.); Department of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy (M.M.); Department of Hematology, Oncology and Stem Cell Transplant, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois (J.F.); Department of Pediatrics, University of California Los Angeles, Los Angeles, California (T.D.); Department of Pediatric Hematoncology, University Hospital de São João, Porto, Portugal (M.J.G.C.); Pediatric Oncology Department, University Hospital Brno, Brno, Czech Republic (J.S.); Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, Graz, Austria (M.B.); Department of Oncology, University Children’s Hospital Zurich, Zurich, Switzerland (N.G.); Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany (R.K.); Department of Neuropathology, University of Bonn, Bonn, Germany (T.P.); Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany (M.K.); Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK (S.C.); Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee (D.W.E.); Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University of Rome, Rome, Italy (F.G.); IRCCS Neuromed, Pozzilli, Italy (F.G.); Department of Pathology, VU University Medical Center, Amsterdam, Netherlands (P.W.); Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands (P.W.); Department of Pathology (Neuropathology), Children’s Hospital Los Angeles and the University of Southern California, Los Angeles, California (F.G.); Telethon Kids Institute, Subiaco, Western Australia (N.G); Department of Pediatrics, Division of Hematology, Oncology and BMT, Nationwide Children’s Hospital and The Ohio State University, Columbus, Ohio (J.L.F.)
